Loading clinical trials...
Loading clinical trials...
Phase II Study of Irinotecan and Carboplatin in Metastatic or Relapsed Small-Cell Lung Cancer
Conditions
Interventions
carboplatin
irinotecan
Locations
1
United States
University of California Davis Cancer Center
Sacramento, California, United States
Start Date
October 1, 2001
Primary Completion Date
August 1, 2008
Completion Date
January 1, 2009
Last Updated
January 10, 2018
NCT07486219
NCT06066138
NCT06498635
NCT07485114
NCT05692635
NCT07336732
Lead Sponsor
University of California, Davis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions